S&P 500   4,078.68 (-0.04%)
DOW   34,388.61 (-0.58%)
QQQ   292.38 (-0.33%)
AAPL   147.21 (-0.55%)
MSFT   252.76 (-0.93%)
META   119.09 (+0.84%)
GOOGL   100.67 (-0.32%)
AMZN   95.83 (-0.74%)
TSLA   194.16 (-0.28%)
NVDA   169.81 (+0.34%)
NIO   12.34 (-3.44%)
BABA   86.15 (-1.61%)
AMD   76.67 (-1.24%)
T   19.13 (-0.78%)
MU   55.42 (-3.87%)
CGC   3.65 (+0.83%)
F   14.13 (+1.65%)
GE   85.48 (-0.57%)
DIS   97.75 (-0.12%)
AMC   8.32 (+15.08%)
PYPL   78.42 (+0.01%)
PFE   50.46 (+0.66%)
NFLX   314.98 (+3.09%)
S&P 500   4,078.68 (-0.04%)
DOW   34,388.61 (-0.58%)
QQQ   292.38 (-0.33%)
AAPL   147.21 (-0.55%)
MSFT   252.76 (-0.93%)
META   119.09 (+0.84%)
GOOGL   100.67 (-0.32%)
AMZN   95.83 (-0.74%)
TSLA   194.16 (-0.28%)
NVDA   169.81 (+0.34%)
NIO   12.34 (-3.44%)
BABA   86.15 (-1.61%)
AMD   76.67 (-1.24%)
T   19.13 (-0.78%)
MU   55.42 (-3.87%)
CGC   3.65 (+0.83%)
F   14.13 (+1.65%)
GE   85.48 (-0.57%)
DIS   97.75 (-0.12%)
AMC   8.32 (+15.08%)
PYPL   78.42 (+0.01%)
PFE   50.46 (+0.66%)
NFLX   314.98 (+3.09%)
S&P 500   4,078.68 (-0.04%)
DOW   34,388.61 (-0.58%)
QQQ   292.38 (-0.33%)
AAPL   147.21 (-0.55%)
MSFT   252.76 (-0.93%)
META   119.09 (+0.84%)
GOOGL   100.67 (-0.32%)
AMZN   95.83 (-0.74%)
TSLA   194.16 (-0.28%)
NVDA   169.81 (+0.34%)
NIO   12.34 (-3.44%)
BABA   86.15 (-1.61%)
AMD   76.67 (-1.24%)
T   19.13 (-0.78%)
MU   55.42 (-3.87%)
CGC   3.65 (+0.83%)
F   14.13 (+1.65%)
GE   85.48 (-0.57%)
DIS   97.75 (-0.12%)
AMC   8.32 (+15.08%)
PYPL   78.42 (+0.01%)
PFE   50.46 (+0.66%)
NFLX   314.98 (+3.09%)
S&P 500   4,078.68 (-0.04%)
DOW   34,388.61 (-0.58%)
QQQ   292.38 (-0.33%)
AAPL   147.21 (-0.55%)
MSFT   252.76 (-0.93%)
META   119.09 (+0.84%)
GOOGL   100.67 (-0.32%)
AMZN   95.83 (-0.74%)
TSLA   194.16 (-0.28%)
NVDA   169.81 (+0.34%)
NIO   12.34 (-3.44%)
BABA   86.15 (-1.61%)
AMD   76.67 (-1.24%)
T   19.13 (-0.78%)
MU   55.42 (-3.87%)
CGC   3.65 (+0.83%)
F   14.13 (+1.65%)
GE   85.48 (-0.57%)
DIS   97.75 (-0.12%)
AMC   8.32 (+15.08%)
PYPL   78.42 (+0.01%)
PFE   50.46 (+0.66%)
NFLX   314.98 (+3.09%)
LON:CREO

Creo Medical Group - CREO Share Forecast, Price & News

GBX 37.48
-0.77 (-2.01%)
(As of 12/1/2022 03:59 PM ET)
Add
Compare
Today's Range
37
▼
38.50
50-Day Range
38.50
▼
63
52-Week Range
37
▼
178.86
Volume
87,030 shs
Average Volume
85,006 shs
Market Capitalization
£68.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CREO stock logo

About Creo Medical Group (LON:CREO) Stock

Creo Medical Group PLC, through its subsidiaries, engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Croma, an energy platform that powers a suite of multi-modal devices to optimize treatments for patients and physicians. The company also offers Speedboat Inject, an energy multimodality instrument for flexible endoscopy; Speedboat Slim, a flexible bipolar RF and microwave device for cutting and coagulation; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highlyperfused tissues; and endotherapy accessories. Creo Medical Group PLC was founded in 2003 and is based in Chepstow, United Kingdom.

Receive CREO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Creo Medical Group and its competitors with MarketBeat's FREE daily newsletter.

CREO Stock News Headlines

November 25, 2022 | uk.finance.yahoo.com
1 penny stock I’d buy for 2023 and hold for a decade
November 4, 2022 | proactiveinvestors.com
Creo Medical under the eye of Proactive research analyst Daniel Appiah
October 24, 2022 | msn.com
The 50 fastest-growing firms in Wales in 2022
October 24, 2022 | lse.co.uk
Creo Medical signs IP and royalty agreement with CMR Surgical
October 24, 2022 | msn.com
The Wales Fast Growth 50, 2022: These are the fastest-growing indigenous firms in Wales
September 15, 2022 | proactiveinvestors.com
US sales boost margins
September 9, 2022 | lse.co.uk
Creo Medical interim loss widens on surging administrative expenses
August 29, 2022 | finance.yahoo.com
Creo Medical Limited (LON:CREO) is favoured by institutional owners who hold 73% of the company
August 24, 2022 | proactiveinvestors.com
Creo Medical growing revenue, products, and training
August 9, 2022 | msn.com
Specialized Turbo Creo SL Expert First Ride Review
August 3, 2022 | msn.com
Life sciences firm Creo Medical forecast strong revenue growth
July 19, 2022 | finance.yahoo.com
The past year for Creo Medical (LON:CREO) investors has not been profitable
July 18, 2022 | msn.com
Gambit Corporate Finance execute £60m in deals in just two weeks
July 6, 2022 | uk.finance.yahoo.com
Creo Medical Limited (CREO.L)
June 4, 2022 | finance.yahoo.com
Is Creo Medical (LON:CREO) A Risky Investment?
May 30, 2022 | proactiveinvestors.com
Creo Medical: Proactive Research’s John Savin talks through his new research report
May 27, 2022 | lse.co.uk
Director dealings: Creo Medical board members add to holdings
May 25, 2022 | finanznachrichten.de
Creo Medical - Solid FY21 followed by robotics deal with Intuitive
May 24, 2022 | proactiveinvestors.com
Creo Medical powering ahead in many areas says CEO Gulliford
May 23, 2022 | lse.co.uk
Creo Medical signs deal with Intuitive; posts widened loss in 2021
May 23, 2022 | marketwatch.com
Creo Medical Signs Collaboration With Intuitive Surgical
April 28, 2022 | proactiveinvestors.com.au
Creo Medical Group sales momentum continuing into 2022
April 20, 2022 | lse.co.uk
TRADING UPDATES: Tatton assets grow; Intosol needs funds
April 5, 2022 | proactiveinvestors.com
Creo says founder and CTO wins 'innovator of the year' award
March 31, 2022 | msn.com
Orthopedics Device Space Gaining Prominence: 3 Stocks in Focus
See More Headlines
Receive CREO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Creo Medical Group and its competitors with MarketBeat's FREE daily newsletter.

CREO Company Calendar

Last Earnings
9/23/2020
Today
12/01/2022
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
Current Symbol
LON:CREO
CUSIP
N/A
CIK
N/A
Web
creomedical.com
Phone
+44-1291-606005
Fax
N/A
Employees
217
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
19.74
Current Ratio
2.66
Quick Ratio
2.19

Sales & Book Value

Annual Sales
£25.90 million
Price / Sales
2.63
Cash Flow
GBX 13.33 per share
Price / Cash Flow
2.81
Book Value
GBX 33.70 per share
Price / Book
1.11

Miscellaneous

Outstanding Shares
181,546,000
Free Float
N/A
Market Cap
£68.04 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Craig Jonathan Gulliford (Age 51)
    CEO & Exec. Director
    Comp: $621.72k
  • Prof. Christopher Paul Hancock (Age 54)
    Founder, CTO & Exec. Director
    Comp: $474.16k
  • Mr. Richard John Rees ACA (Age 45)
    CFO, Company Sec. & Exec. Director
    Comp: $472.35k
  • Mr. David Gerard Woods (Age 56)
    Chief Commercial Officer & Exec. Director
    Comp: $555.86k
  • Mr. Phil Hales
    Sales & Marketing Director

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













CREO Stock - Frequently Asked Questions

How have CREO shares performed in 2022?

Creo Medical Group's stock was trading at GBX 148.60 at the start of the year. Since then, CREO stock has decreased by 74.3% and is now trading at GBX 38.25.
View the best growth stocks for 2022 here.

How were Creo Medical Group's earnings last quarter?

Creo Medical Group PLC (LON:CREO) released its earnings results on Wednesday, September, 23rd. The company reported ($6.00) earnings per share (EPS) for the quarter.

What other stocks do shareholders of Creo Medical Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Creo Medical Group investors own include MySQUAR (MYSQ) and IQE (IQE).

What is Creo Medical Group's stock symbol?

Creo Medical Group trades on the London Stock Exchange (LON) under the ticker symbol "CREO."

How do I buy shares of Creo Medical Group?

Shares of CREO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Creo Medical Group's stock price today?

One share of CREO stock can currently be purchased for approximately GBX 38.25.

How much money does Creo Medical Group make?

Creo Medical Group (LON:CREO) has a market capitalization of £69.44 million and generates £25.90 million in revenue each year.

How many employees does Creo Medical Group have?

The company employs 217 workers across the globe.

How can I contact Creo Medical Group?

The official website for the company is creomedical.com. The company can be reached via phone at +44-1291-606005.

This page (LON:CREO) was last updated on 12/1/2022 by MarketBeat.com Staff